Oncocyte Corp
OCX
Revenue
260.00k
▼-258.00k▼-49.81%
3 Months ChangeAssets
43.94M
▼-6.58M▼-13.03%
3 Months ChangeLiabilities
53.13M
▲3.71M▲7.52%
3 Months ChangeFree Cash Flow
-6.17M
▼-2.31M▼-59.96%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-15
Form 8-K
ID: 0001493152-24-041133
2024-10-03
Form 8-K
ID: 0001493152-24-039269
2024-08-09
Form 8-K
ID: 0001493152-24-030865
2024-08-08
Form 10-Q
ID: 0001493152-24-030793
2024-08-08
Form 8-K
ID: 0001493152-24-030771
2024-07-12
Form 8-K
ID: 0001493152-24-027086
2024-07-05
Form 8-K
ID: 0001493152-24-026335
2024-06-17
Form 8-K
ID: 0001493152-24-024108
2024-05-31
Form 8-K
ID: 0001493152-24-022193
2024-05-23
Form 8-K
ID: 0001493152-24-021144